Recent Updates
Recently added Catalysts
MXCT Positive Sentiment

MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023

Thursday, July 13, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: MaxCyte, Inc. has announced that it will release its financial results for the second quarter of 2023 on August 9, 2023, after U.S. market close. The company, which specializes in cell-engineering technologies, will host a conference call at 4:30 p.m. Eastern Time to discuss the financial outcomes. Interested investors are encouraged to register for the call in advance, with a live and archived webcast available on MaxCyte's website.
Price reaction · baseline $5 (2023-07-12 close) · hit after-hours · clean, no other MXCT news in the window
day 0 close · peak
+0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • MaxCyte is positioned as a leader in cell-engineering technologies.
  • The upcoming financial report indicates company transparency and investor engagement.
  • The scheduled conference call presents an opportunity for investors to gain insights.

Full Press Release Details

ROCKVILLE, Md., July 13, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative cell-based research, today announced that it will release financial results for the second quarter 2023 after the U.S. market close on Wednesday, August 9th, 2023. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
Consilium Strategic Communications
Mary-Jane Elliott / Chris Welsh

Frequently Asked Questions

When will MaxCyte release its Q2 2023 financial results?

MaxCyte will announce its Q2 2023 financial results after the market closes on August 9, 2023.

What time is the earnings conference call for Q2 2023?

The earnings conference call is scheduled for 4:30 p.m. Eastern Time on August 9, 2023.

How can investors listen to the conference call?

Investors must register online at least a day in advance to listen to the conference call.

Where can I find the webcast of the conference call?

The live and archived webcast will be available in the 'Events' section of the MaxCyte website.

Who are the nominated advisers for MaxCyte?

Emma Earl and Freddy Crossley are nominated advisers for MaxCyte, along with Consilium Strategic Communications.

ShareAdd on Google
Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte financial results cell-engineering conference call
Last updated: Jul 13, 2023

Biotech snapshot

Cash runway
$106M liquidity · $2M/mo burn
~67 mo
Minimal dilution risk